Phase II Trial of Bevacizumab in Combination with XELOX in Colorectal Cancer Patients with Liver Metastases (H2, H3).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 May 2016
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 15 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 23 Dec 2009 New trial record